Elinor Bexe Lindskog
-
Isobaric labeling-based quantitative proteomics of FACS-purified immune cells and epithelial cells from the intestine of Crohn's disease patients reveals proteome changes of potential importance in disease
pathogenesis.
Johannes Alfredsson, Ivo Fabrik, Frida Gorreja, Charles Caër, Carina Sihlbom, Mattias Block, Lars Börjesson, Elinor Bexe-Lindskog, Mary Jo Wick
Proteomics - 2023 -
Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal
Cancer
Fanny Andric, Ala Al-Fairouzi, Yvonne Wettergren, Louis Szeponik, Elinor Bexe-Lindskog, J. C. Cusack, G. Tumusiime, Marianne Quiding-Järbrink, David Ljungman
Cancers - 2023 -
Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal
cancer
Donia Kaidi, Louis Szeponik, Ulf Yrlid, Yvonne Wettergren, Elinor Bexe-Lindskog
Clinical & Translational Oncology - 2022 -
Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon
Cancer
Helena Taflin, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren, Elinor Bexe-Lindskog
Cancers - 2022 -
MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn ' s Disease
Patients
Frida Gorreja, Charles Caër, Stephen T.A Rush, Sophia K. Forsskål, Anetta Härtlova, Maria K Magnusson, Elinor Bexe-Lindskog, Lars Börjesson, Mattias Block, Mary Jo Wick
Inflammation - 2022 -
Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon
cancer
Frans Emland, Helena Taflin, Göran Carlsson, David Ljungman, Elinor Bexe-Lindskog
World Journal of Surgical Oncology - 2022 -
5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical
information
Simona Salerno, Anders Ståhlberg, André Holdfeldt, Elinor Bexe-Lindskog, Göran Landberg
Journal of Translational Medicine - 2022 -
TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease
Patients
Charles Caër, Frida Gorreja, Sophia Forsskåhl, Siggeir Brynjolfsson, Louis Szeponik, Maria K Magnusson, Lars G. Börjesson, Mattias Block, Elinor Bexe-Lindskog, Mary Jo Wick
Journal of Crohn's & colitis - 2021 -
Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer
patients
William Rodin, Patrik Sundström, Filip Ahlmanner, Louis Szeponik, Kamil Kajetan Zajt, Yvonne Wettergren, Elinor Bexe-Lindskog, Marianne Quiding Järbrink
Cancer Immunology Immunotherapy - 2021 -
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T
Cells.
Frank Liang, Azar Rezapour, Louis Szeponik, Samuel Alsén, Yvonne Wettergren, Elinor Bexe-Lindskog, Marianne Quiding-Järbrink, Ulf Yrlid
Cancers - 2021 -
Patient-derived scaffolds as a model of colorectal
cancer
Gabrielle T. Parkinson, Simona Salerno, Parmida Ranji, Joakim Håkansson, Y. Bogestal, Yvonne Wettergren, Anders Ståhlberg, Elinor Bexe-Lindskog, Göran Landberg
Cancer Medicine - 2021 -
Regulatory T cells reduce endothelial neutral sphingomyelinase 2 to prevent T-cell migration into
tumors
Paulina Akeus, Louis Szeponik, Veronica Langenes, Viktoria Karlsson, Patrik Sundström, Elinor Bexe-Lindskog, C. Tallon, B. S. Slusher, Marianne Quiding-Järbrink
European Journal of Immunology - 2021 -
Intratumoral regulatory T cells from colon cancer patients comprise several activated effector
populations
Louis Szeponik, Filip Ahlmanner, Patrik Sundström, William Rodin, Bengt Gustavsson, Elinor Bexe-Lindskog, Yvonne Wettergren, Marianne Quiding-Järbrink
Bmc Immunology - 2021 -
Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and
survival
Hamideh Salimzadeh, Elinor Bexe-Lindskog, Bengt Gustavsson, Yvonne Wettergren, David Ljungman
Bmc Cancer - 2020 -
Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector
molecules.
Patrik Sundström, Louis Szeponik, Filip Ahlmanner, Malin Sundquist, Justin S B Wong, Elinor Bexe-Lindskog, Bengt I. Gustafsson, Marianne Quiding-Järbrink
Oncotarget - 2019 -
Long-term mucosal injury and repair in a murine model of pelvic
radiotherapy
Dilip Malipatlolla, Piyush Patel, Fei Sjöberg, Sravani Devarakonda, Marie Kalm, Eva Angenete, Elinor Bexe-Lindskog, Rita Grander, Linda Persson, A. Stringer, Ulrica Wilderäng, John Swanpalmer, Hans-Georg Kuhn, Gunnar Steineck, Cecilia Bull
Scientific Reports - 2019 -
CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive
function
Filip Ahlmanner, Patrik Sundström, Paulina Akeus, Jenny Eklöf, Lars Börjesson, Bengt Gustavsson, Elinor Bexe-Lindskog, Sukanya Raghavan, Marianne Quiding-Järbrink
Oncotarget - 2018 -
Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk
loci
T. Tanskanen, L. van den Berg, N. Valimaki, M. Aavikko, E. Ness-Jensen, K. Hveem, Yvonne Wettergren, Elinor Bexe-Lindskog, N. Tonisson, A. Metspalu, K. Silander, G. Orlando, P. J. Law, S. Tuupanen, A. E. Gylfe, U. A. Hanninen, T. Cajuso, J. Kondelin, A. P. Sarin, E. Pukkala, P. Jousilahti, V. Salomaa, S. Ripatti, A. Palotie, H. Jarvinen, L. Renkonen-Sinisalo, A. Lepisto, J. Bohm, J. P. Mecklin, N. A. Al-Tassan, C. Palles, L. Martin, E. Barclay, A. Tenesa, S. M. Farrington, M. N. Timofeeva, B. F. Meyer, S. M. Wakil, H. Campbell, C. G. Smith, S. Idziaszczyk, T. S. Maughan, R. Kaplan, R. Kerr, D. Kerr, D. D. Buchanan, A. K. Win, J. Hopper, M. A. Jenkins, P. A. Newcomb, S. Gallinger, D. Conti, F. R. Schumacher, G. Casey, J. P. Cheadle, M. G. Dunlop, I. P. Tomlinson, R. S. Houlston, K. Palin, L. A. Aaltonen
International Journal of Cancer - 2018 -
A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal
cancer.
Elinor Bexe-Lindskog, Katrín Asta Gunnarsdóttir, Kristoffer Derwinger, Yvonne Wettergren, Bengt Glimelius, Karl Kodeda
BMC cancer - 2014 -
Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal
cancer.
Elinor Bexe-Lindskog, Kristoffer Derwinger, Bengt Gustavsson, Peter Falk, Yvonne Wettergren
BMC clinical pathology - 2014 -
Experimental and population-based studies on colorectal cancer - Thymidine phosphorylase as a potential
biomarker
Elinor Bexe-Lindskog
2014 -
Changes in thymidine phosphorylase gene expression related to treatment of rectal
cancer.
Kristoffer Derwinger, Elinor Bexe-Lindskog, Erik Palmqvist, Yvonne Wettergren
Anticancer research - 2013 -
Thymidine Phosphorylase Gene Expression in Stage III Colorectal
Cancer.
Elinor Bexe-Lindskog, Yvonne Wettergren, Elisabeth Odin, Bengt Gustavsson, Kristoffer Derwinger
Clinical Medicine Insights. Oncology - 2012 -
Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal
cancer.
Kristoffer Derwinger, Karl Kodeda, Elinor Bexe-Lindskog, Helena Taflin
Acta oncologica - 2010 -
Tymidinfosforylas, en prediktiv markör för 5-FU-baserad cytostatikabehandling vid kolorektal
cancer
Elinor Bexe-Lindskog, Yvonne Wettergren, Kristoffer Derwinger, Bengt Gustavsson
Svensk Kirurgisk Förening - 2010 -
Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related
genes.
Bengt Gustavsson, Christopher Kaiser, Göran Carlsson, Yvonne Wettergren, Elisabeth Odin, Elinor Bexe-Lindskog, Clet Niyikiza, Doreen Ma
International journal of cancer. Journal international du cancer - 2009